Table 1 Baseline and clinical characteristics
From: Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke
Controls (n = 61) | Patients | ||
|---|---|---|---|
6 h (n = 80) | 48 h (n = 85) | ||
Demographic characteristics | |||
Age ≥ 50 years, n (%) | 52 (85) | 75 (94) | 73 (86) |
Gender, (M/F) | 26/35 | 33/47 | 49/36 |
Race caucasian, n (%) | 61 (100) | 80 (100) | 82 (96) |
Risk factors, n (%) | |||
Hypertension | 15 (24) | 60 (75)***, # | 60 (70)** |
Diabetes | 3 (5) | 11 (14) | 29 (34)***, ## |
Dyslipidemia | 12 (20) | 43 (54)*** | 39 (46) |
Cardiovascular diseases | 2 (3) | 24 (30)*** | 19 (22) |
Atrial fibrillation | 2 (3) | 30 (37)*** | 15 (18)* |
Smoking history | 22 (37) | 21 (26) | 44 (57) |
Recent Infections | 2 (3) | – | 1 (1) |
CRP ≥ 3 mg/l | – | 5 (6) | 16 (19) |
Clinical characteristics | |||
TOAST classification, n (%) | |||
Cardioembolism | 24 (30) | 23 (27) | |
Atherosclerosis | 21 (26) | 33 (39) | |
Small vessel occlusion | 11 (14) | 6 (7) | |
Undetermined etiology | 24 (30) | 22 (25) | |
Other determined etiology | – | 2 (2) | |
NIHSS, median (IQR) | 5 (2–11) | 5 (2–11) | |
Severe (>14), n (%) | 12 (16) | 14 (17) | |
3-month mRS, median (IQR) | 2 (1–4) | 1 (0–3) | |
mRS (>2), n (%) | 33 (41) | 36 (42) | |
Mortality | 10 (12) | 2 (3) | |